Kevin is a second-year undergraduate student at Stanford University studying bioengineering. After his time there, he hopes to pursue an MD/PhD dual degree with a specific interest in neurosurgery. He joined the Petritsch lab in September of 2023 and has been helping to explore the therapeutic potential of the BRAF V600E peptide vaccine in inhibiting glioma formation and modulating immune response in a novel high-grade glioma mouse model. Additionally, Kevin enjoys/partakes in visual arts, dance, music, and theater. He also is working on a public policy start-up initiative called BIO4E which hopes to democratize biology. Support this project here: https://bio4e.sites.stanford.edu/ !
